Reducing Lead Dust Exposure in Older Housing
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: portable air filtration systems.
- Who it may be relevant to
- Registry conditions: Exposure to Toxic Dust, Elevated Blood Lead Levels. Basic parameters: up to 7 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Reducing Lead Dust Exposure and Childhood Blood Lead Levels in Older Housing in Michigan
Overview
The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
Detailed description
In close collaboration with local health departments, this project will enroll 40 participants who (1) reside in housing built before 1970, and (2) have children under six years of age with blood lead levels (BLL) \>5 μg/dL. Specific objectives include (1) assess reduction of Pb dust exposure via the intervention, (2) assess the ability of PAF to reduce childhood BLL indirectly via reductions in Pb dust exposure, and (3) develop evidence-based exposure reduction guidance for wider public use of PAF. The project team will measure Pb levels in (1) suspended dust, (2) floor dust, and (3) children's blood before the start and finish of the two-month-long intervention as well as at the midpoint.
Interventions
- Other portable air filtration systems
Two portable air filtration units placed in subjects' homes (one in child's bedroom and one in living room) will be kept running for two months.
Primary outcome measures
- Change in blood lead level [Time frame: After two months at the end of the intervention]
Eligibility criteria
Inclusion criteria
- child under seven years of age with BLL >5 µg/dL,
- child must reside in housing built before 1978, and
- child must sleep at home during participation in the two month-long study.
Exclusion criteria
- anything in child's health history that could affect the study results, or
- any circumstance that could interfere with guardian's/parent's ability to consent and/or participate in the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- Michigan State University — East Lansing
Identifiers
NCT: NCT07485608 · MILTS0025-21